Abiopharma

Director FARRELL MATTHEW 🟢 acquired 1.8K shares (1 derivative) of NOVANTA INC (NOVT) Transaction Date: Jan 02, 2026 | Filing ID: 000007

📋 AUERBACH ALAN H (Officer) plans to sell 17K shares of PUMA BIOTECHNOLOGY, INC. (at $5.84 each, total $99K) Filed: Jan 06, 2026 | ID: 000165

📋 Zuga Matt (Officer) plans to sell 5K shares of Acumen Pharmaceuticals, Inc. (at $1.97 each, total $10K) Filed: Jan 06, 2026 | ID: 000012

📋 Utter Christine Marie (Officer) plans to sell 1K shares of PTC THERAPEUTICS, INC. (at $76.95 each, total $106K) Filed: Jan 06, 2026 | ID: 000164

Piscitelli Dominic 🟢 acquired 241.0K shares (2 derivative) of Oric Pharmaceuticals, Inc. (ORIC) at $8.17 ($1.7M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Director Protopapas Anna 🔴 sold 83.3K shares (17 derivative) of Mersana Therapeutics, Inc. (MRSN) at $355.75 ($10.0M) Transaction Date: Jan 06, 2026 | Filing ID: 001374

Multani Pratik S 🟢 acquired 249.5K shares (2 derivative) of Oric Pharmaceuticals, Inc. (ORIC) at $8.17 ($1.7M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Director Carpenter Lonny J. 🟡 adjusted position in 1.8K shares (2 derivative) of NOVANTA INC (NOVT) Transaction Date: Jan 02, 2026 | Filing ID: 000005

New Form SCHEDULE 13G - ImageneBio, Inc. Filed: 2026-01-06 AccNo: 0002073679-26-000001 Size: 102 KB

Lowinger Timothy B 🔴 sold 58.5K shares (21 derivative) of Mersana Therapeutics, Inc. (MRSN) at $527.25 ($6.9M) Transaction Date: Jan 06, 2026 | Filing ID: 001371

📋 OConnell Daniel Joseph (Officer) plans to sell 5K shares of Acumen Pharmaceuticals, Inc. (at $1.97 each, total $10K) Filed: Jan 06, 2026 | ID: 000011

📋 Sara Bonstein (Officer) plans to sell 2K shares of INSMED INC (at $173.33 each, total $263K) Filed: Jan 06, 2026 | ID: 000936

Cousin Laetitia 🔴 sold 140 shares of INSULET CORP (PODD) at $282.92 Transaction Date: Jan 02, 2026 | Filing ID: 000005

Chacko Jacob 🟢 acquired 787.5K shares (2 derivative) of Oric Pharmaceuticals, Inc. (ORIC) at $8.17 ($5.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Mainolfi Nello 🟡 adjusted position in 0 shares (1 derivative) of Kymera Therapeutics, Inc. (KYMR) at $32.07 Transaction Date: Jan 05, 2026 | Filing ID: 004641